Concept Elicitation and Patient Experience Mapping in SA-AKI (NCT07180238) | Clinical Trial Compass
CompletedNot Applicable
Concept Elicitation and Patient Experience Mapping in SA-AKI
United States28 participantsStarted 2025-05-01
Plain-language summary
This is a concept elicitation study on patient's experiences of Sepsis-associated Acute Kidney Injury (SA-AKI)
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Potential participants who were diagnosed with SA-AKI (KDIGO stage I, II or III) must meet the following eligibility criteria:
* ≥18 to ≤ 85 years of age
* First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years
* Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay.
* Resident of country of study (US or Germany)
* Access to computer, tablet, or smartphone with internet connection
* Willing to participate in an audio recorded interview
Participants will be required to present confirmation of diagnosis (COD) rather than relying on a self-reported diagnosis. Sepsis and AKI diagnoses will be confirmed through one of the following:
* Copy of medical records (e.g., portable document format \[PDF\] file of electronic health record)
* Physician confirmation of diagnosis of sepsis and AKI (post-sepsis)
Potential caregiver participants must meet the following criteria:
* ≥18 to ≤ 85 years of age
* Primary caregiver/care-partner for eligible participant who experienced SA-AKI
* Resident of country of study (US or Germany)
* Access to computer, tablet, or smartphone with internet connection
* Willing to participate in an audio recorded interview
Exclusion Criteria:
Potential participants are not eligible if they meet any of the following criteria:
* Less than age of majority in loca…
What they're measuring
1
Patient perspective on sign, symptoms and impacts of SA-AKI